| 儿童肝母细胞瘤的诊疗进展 |
| |
| 引用本文： | 汤梦婕,袁晓军.儿童肝母细胞瘤的诊疗进展[J].第二军医大学学报,2015,36(3):315-319. |
| |
| 作者姓名： | 汤梦婕 袁晓军 |
| |
| 作者单位： | 上海交通大学医学院附属新华医院儿童血液/肿瘤科,上海,200092 |
| |
| 摘 要： | 肝母细胞瘤(hepatoblastoma,HB)是儿童最常见的肝脏恶性肿瘤,其诊疗方式在近30年逐渐改变,从单一的手术切除治疗发展为多学科综合治疗模式.目前,各大研究中心着重关注于患儿的危险度分组及分层治疗,并在不断寻找新的潜在与预后相关的高危因素.本文从病因学、临床诊断、危险度分组标准、治疗原则及预后因素等方面综述HB的研究进展.
|
| 关 键 词： | 肝母细胞瘤 儿童 综合疗法 |
| 收稿时间： | 2014/11/30 0:00:00 |
| 修稿时间： | 2015/2/10 0:00:00 |
Diagnosis and treatment of hepatoblastoma in children: recent progress |
| |
| TANG Meng-jie and YUAN Xiao-jun.Diagnosis and treatment of hepatoblastoma in children: recent progress[J].Academic Journal of Second Military Medical University,2015,36(3):315-319. |
| |
| Authors: | TANG Meng-jie and YUAN Xiao-jun |
| |
| Institution: | Department of Pediatric Hematology/Oncology, Xinhua Hospital, Shanghai Jiaotong University School of Medicine, Shanghai 200092, China*Corresponding author |
| |
| Abstract: | Hepatoblastoma is the most commonly-seen liver tumor in children. The past 30 years has witnessed graduall changes in the diagnosis and treatment of HB: from single operative excision to multimodality therapies. Recently many research groups have focused on the risk groups and stratified treatment, looked for novel potential prognostic risk factors. This paper reviewed the etiology, clinical diagnosis, criterion of risk groups, treatment principle, and prognosis factors of hepatoblastoma in children. |
| |
| Keywords: | Hepatoblastoma Children Multimodality therapy |
| 本文献已被 CNKI 万方数据 等数据库收录！ |
| 点击此处可从《第二军医大学学报》浏览原始摘要信息 |
| 点击此处可从《第二军医大学学报》下载免费的PDF全文 |
|
